Second-trimester Down's syndrome serum screening: Double, triple or quadruple marker testing?

Annals of Clinical Biochemistry

Volumn 43, Issue 1, 2006, Pages 67-72

  Harrison, G ^a   Goldie, D ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; INHIBIN A; MARKER;

ACCURACY; ADULT; ARTICLE; ASSAY; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; DOWN SYNDROME; FALSE POSITIVE RESULT; FEMALE; HUMAN; MATERNAL SERUM; PREGNANCY; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; GREAT BRITAIN; HUMANS; INHIBINS; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES; RISK FACTORS; SOFTWARE;

EID: 30844463470     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456306775141876     Document Type: Article

References (13)

1. Department of Health. CMO's update Number 31 October 2001: Down syndrome screening. www.doh.gov.org/cmo/cmoh.htm
2. Wald NJ, Rodek C, Hacksaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003; 7
3. http//www.nelh.nhs.uk/screening/antenatal_pps/down.html. Model of Best Practice. November 2003
4. National Institute for Clinical Excellence. Antenatal Care: Routine Care for the Healthy Pregnant Woman. Clinical Guideline 2003. RCOG Press
5. Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. BJOG 1987; 94: 387-402
6. Reynolds TM, Penney MD. The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy. Ann Clin Biochem 1990; 27: 452-8
7. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988; 297: 883-7
8. Altman D. Practical Statistics for Medical Research. London: Chapman and Hall, 1991
9. Erickson JA, Ashwood ER, Gin CA. Evaluation of a dimeric inhibin-A assay for assessing fetal Down's syndrome: establishment, comparison and monitoring of median concentrations for normal pregnancies. Arch Pathol Lab Med 2004; 128: 415-20
10. Wald NJ, Kennard A, Hacksaw A, McGuire A. Antenatal Screening for Down's syndrome. J Med Screen 1997; 4: 181-246
11. Haddow J, Palomaki GE, Knight GJ, Foster DL, Neveux LM. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin-A. Am J Med Screen 1998; 5: 115-9
12. Aitken DA, Wallace EM, Crossley JA, Swanston IA, van Pareren Y. Dimeric inhibin-A as a marker for Down's syndrome in early pregnancy. New Engl J Med 1996; 19: 1231-6
13. Beaman JM, Goldie DJ. Second trimester screening for Down's syndrome: 7 years experience. J Med Screen 2001; 8: 128-31